University of Ioannina
Essential oil loaded collagen hydrogels to battle bacterial infections for tissue engineering applications
Abstract
dc:descriptionIncreased consumption and misuse of antimicrobial agents in both humans and animals have contributed to the spread of antimicrobial resistance, which seriously threatens public and animal health. Whereas infections due to antimicrobial resistance exhibited by bacteria can be adaptive, intrinsic, and acquired, multidrug-resistant bacteria (e.g., methicillin-resistant Staphylococcus aureus) cause infections that end up with longer hospitalization periods, remarkable morbidity, and mortality, as well as high healthcare costs. According to Organization of Economic Cooperation and Development (OECD) report, approximately 2.4 million people are expected to die due to this kind of infection in North America, Australia, and Europe over the next three decades, and treatment cost may reach USD 3.5 billion per year. In general, S. aureus is one of the major opportunistic human pathogens, which can escape the immune system. Among the wide variety of infections, S. aureus is a well-known bacterium associated with wound infections, where the outermost layer of wounds is colonized. In particular, S. aureus-caused infections may be evaluated as a potential risk factor for methicillin-resistant S. aureus (MRSA) concern, which has brought about the need for development of alternative antimicrobials to substitute traditional antibiotics. Moreover, S. aureus (especially MRSA) has the ability to adhere to living or inert surfaces, secreting an extracellular polymeric substance of proteins, polysaccharides, nucleic acids, and water, known as a biofilm. Subsequently, the biofilm matrix acts as a physical barrier that prevents the permeability of the drug into the bacterial community and helps the microbe resist and minimize the effect of traditional antibiotics. These challenges have given rise to a significant interest in the scientific community in developing herbal-based therapeutics with antimicrobial activity (e.g., essential oils) as a safer and green alternative to antibiotics. Essential oils (EOs) are colored, aroma-rich, complex hydrophobic liquids, also known as volatile oils. They are defined as the secondary metabolic product of aromatic plants and are found in various plant parts such as flowers, roots, barks, stems, leaves, and seeds. EOs are potential agents to diminish antimicrobial resistance due to their significant therapeutic properties (i.e., antibacterial, antiseptic, and antioxidant activities). For this reason, EOs from pharmaceutical plants have also been examined as potent antimicrobial agents in animal production systems. The antimicrobial activity of EOs does not only stem from their qualitative chemical composition, but also from the quantitative intensity of every single component that is included in the structure, as well as all plant-based products. Their complex composition mainly includes terpenes (generally monoterpenes and sesquiterpenes) and terpenoids. Even though some of these chemicals are water soluble, most of them are hydrophobic, so EOs are defined as hydrophobic. In this study, EOs of Thymus sibthorpii, Origanum vulgare, Salvia fruticosa, and Crithmum maritimum plants were chosen as the potential antimicrobial agents against various S. aureus strains to deal with the antimicrobial resistance problem. All these plant species have already been incorporated in traditional medications due to their potential anti-inflammatory, antimicrobial, antioxidant, and anti-cancer properties. The antimicrobial activities of the above four EOs were screened against methicillin-sensitive S. aureus (MSSA), MRSA, and the reference strain S. aureus ATCC 29213 applying the Kirby–Bauer disc diffusion and broth microdilution methods. The modified microtiter plate biofilm assay was also performed to assess the biofilm formation ability of tested strains, and the anti-biofilm activity of EOs, as well as reference antimicrobials. Staphylococcus epidermidis (S. epidermidis) ATCC 12228 and S. epidermidis 35984 were used as negative and positive quality control strains, respectively, for this bioassay. Penicillin, enrofloxacin, gentamicin sulfate, tetracycline hydrochloride, and cefaclor were examined as reference antimicrobials in this context. The observed bacterial growth inhibition varied significantly depending on the type and concentration of the antimicrobials. Thymus sibthorpii EO was determined as the strongest antimicrobial, with 0.091 mg/mL minimum inhibitory concentration (MIC) and a 14–33 mm diameter inhibition zone at 5% (v/v) concentration. All tested EOs indicated almost 95% inhibition of biofilm formation at their half MIC, while gentamicin sulfate did not show sufficient anti-biofilm activity. None of the methicillin-resistant strains showed resistance to the EOs compared to methicillin-sensitive strains. Thus, Thymus sibthorpii and Origanum vulgare EOs might be determined potential antimicrobial agent alternatives to overcome the problem of microbial resistance. Although the strong antimicrobial activity of Thymus sibthorpii EO was revealed in the first experimental chapter of this study, a type of administration is needed via a biomaterial system, because of the high sensitivity and volatility of EO. Among a wide variety of biomaterial formulations, collagen hydrogels have been reported as particularly effective for incorporating essential oils to use in tissue engineering applications. On the other hand, to our best knowledge, Thymus sibthorpii EO has not been introduced yet within medical devices in the field of tissue engineering applications according to the literature. Collagen, a fibrous, non-soluble protein, is one of the most prominent polymers for the development of antimicrobial biomaterials, attributable to its superior biocompatibility, excellent biodegradability, hydrophilic nature, reduced cytotoxicity, and high cell attachment affinity. Nevertheless, the fabricated forms of collagen need to be functionalized via in situ crosslinking due to a lack of stability. Since physical and biological crosslinking mechanisms have generally resulted in low crosslinking efficacy, carboxyl, and amine terminal crosslinking strategies are favored in research, as arises in literature. Among the above, since carbodiimide and glutaraldehyde often cause cytotoxicity, alternative crosslinkers such as multi-arm, star-shaped poly(ethylene glycol) succinimidyl glutarate (starPEG) have emerged as the subject of research. At the second experimental part of this study, at first crosslinking efficiency was screened. For this purpose, 300 μl collagen type I hydrogels crosslinked with six different starPEG molecules were developed and optimized, followed by assessment of free amine content of the hydrogels using TNBSA assay, and evaluation of their enzymatic degradation profile using collagenase assay. Furthermore, the optimally starPEG-crosslinked collagen hydrogels were loaded with several concentrations (0.5, 1, 2% v/v) of Thymus sibthorpii EO and the release profile and kinetics of the EO were investigated. For this purpose, the fabricated EO-loaded hydrogels were soaked into 1 mL of 1x PBS (pH 7.4) at 37 C using a horizontal shaker incubator. At each defined time point (0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 24, and 48 h), 100 μL of sample was removed and replaced by 100 μL fresh 1x PBS. The linear calibration curve was prepared with different concentrations of Thymus sibthorpii EO using 70% v/v ethanol, which was used as a solvent. Then, the absorbance of the supernatant was measured at 365 nm and the concentration of the released Thymus sibthorpii EO was determined by using the standard curve to find where their concentration corresponds. After spectrophotometric evaluation, the cumulative release percentage of EO was estimated. Furthermore, we studied the release kinetics according to the release profile of Thymus sibthorpii EO. Hence, the zero-order, first-order, Higuchi, Korsmeyer-Peppas, and Hixon-Crowell release kinetics models have been applied to post-burst-release data. Finally, the antimicrobial activity of the developed composite hydrogels was assessed against S. aureus, and Escherichia coli (E. coli) using Kirby-Bauer disc diffusion method, whilst their cytocompatibility and cytotoxicity was examined on NIH-3T3 fibroblast cell line by alamarBlue cell viability assay, and Quant-iT PicoGreen dsDNA cell proliferation assay.starPEG-crosslinked collagen type I hydrogels presented significantly decreased free amine content for all types of crosslinkers with all tested concentrations compared to non-crosslinked hydrogels (p < 0.05). An effective plateau was observed between 0.5 and 2 mM, and no statistical difference was noted among 0.5 mM, 1 mM, and 2 mM crosslinked hydrogels (p < 0.05). In this plateau, the free amine reduction percentage was between 44.82% and 58.57%. Non-crosslinked hydrogels were completely degraded within a couple of hours. In general perspective, scaffolds showed higher resistance to degradation when crosslinked with glutaraldehyde (GTA), that was used as a positive control. However, hydrogels crosslinked with 0.5 mM of 4SP, pentaerythritol, 10 kDa showed no statistical difference compared to GTA crosslinked hydrogels, whilst 0.5 mM of 4SP, pentaerythritol, 20 kDa, and 8SP, hexaglycerol, 20 kDa displayed the lowest significant difference than all other groups (p < 0.05). Therefore, 0.5 mM of the above three crosslinkers were deemed to be optimal conditions for functionalizing collagen hydrogels. The non-crosslinked hydrogels demonstrated burst release and completely released EO within a couple of hours was observed. Although GTA crosslinked scaffolds released almost all loaded quantity of the EO at 0.5% v/v from the polymeric network, the chosen optimized hydrogels crosslinked with 0.5 mM of 4SP, pentaerythritol, 10 kDa, 4SP, pentaerythritol, 20 kDa and 8SP, hexaglycerol, 20 kDa, released 63.92 3.31%, 75.85 9.00% and 57.82 4.08% of the EO loaded at the same concentration after 48 h. Moreover, the release kinetics was studied by applying five different mathematical models. Hixson-Crowell model did not fit any of the experimental groups, whilst the other four models fitted to different experimental groups. On the other hand, the release exponent (n) values evaluated by the Korsmeyer-Peppas model indicated that the release mechanism of EO from crosslinked hydrogels obeyed the Fickian diffusion. 0.5% v/v EO-loaded collagen type I hydrogels showed adequate antibacterial activity against S. aureus. More specifically, hydrogels crosslinked with 0.5 mM 4SP, pentaerythritol, 10 kDa and loaded with 0.5 v% EO demonstrated 2.83 0.47 cm, and 1.23 0.15 cm inhibition zone diameter against S. aureus, and E. coli, respectively. Moreover, hydrogels containing 0.5% v/v of EO, which was the minor concentration, did not show a statistical difference regarding their antimicrobial activity compared to positive control penicillin (for gram-positive bacteria), and enrofloxacin (for gram-negative bacteria) (p < 0.05). Hence, 0.5% v/v concentration of Thymus sibthorpii EO was chosen as the optimal concentration to incorporate into collagen scaffolds. According to cell metabolic activity and proliferation studies, none of the fabricated hydrogels showed any toxicity on ΝΙΗ-3Τ3 fibroblast cell line (p < 0.05).In the quest for alternative antibacterial therapies, herein, we developed collagen type I hydrogel systems optimally crosslinked and loaded with Thymus sibthorpii essential oil. The proposed antimicrobial agent incorporated into the collagen type I scaffolds showed strong activity against S. aureus, demonstrated a sustained release profile, and had no toxicity on fibroblasts. Collectively, the outcomes obtained highlight the importance of Thymus sibthorpii essential oil incorporated in collagen type I hydrogels, as an effective and alternative antibacterial therapy for regenerative medicine and tissue engineering purposes and for the reduction of the possible antimicrobial resistance.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ersanli, Çağlar
- Ερσανλί, Τσάγλαρ
Subjects
dc:subject × 18- Βιοϋλικά
- Μηχανική ιστών
- Κολλαγόνο
- Αντιβακτηριακή υδρογέλη
- Αιθέρια έλαια
- Αντιμικροβιακή αντοχή
- Biomaterials
- Tissue engineering
- Collagen
- Antibacterial hydrogels
- Essential oil
- Antimicrobial resistance
- Βιοϊατρική Μηχανική
- Επιστήμες Μηχανικού και Τεχνολογία
- Μηχανική κυττάρων και ιστών
- Medical Engineering
- Engineering and Technology
- Cell and Tissue Engineering
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58978